(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Audits of Espresso Types: Which Mix Is for You? - 2Find the Wonders of the Silk Street: Following the Antiquated Shipping lanes
- 3'Israel has the right to continue its attacks,' Lebanese Foreign Minister announces
- 4NASA wants to build a base on the Moon by the 2030s – how and why it plans to build up to a long-term lunar presence
- 5Mosquitoes carrying malaria are evolving more quickly than insecticides can kill them – researchers pinpoint how
- Going with Children: Tips for Tranquil Family Get-aways
- Vote In favor of Your Favored Kind Of Organic product
- 6 Natural products High In Vitamins,Which One Do You Like to Eat
- Find the Wonders of the Silk Street: Following the Antiquated Shipping lanes
- 4 Masked Men Steal Renoir, Matisse and Cézanne Paintings Worth Over $10 Million in 3-Minute Heist
- Best Pizza Beating: What's Your #1?
- I'm 18 and founded an AI startup. I have to wake up at 3 a.m. to work on it before school, but it's worth every sleepless night.
- Figure out how to Amplify Your Open Record Reward
- IDF strikes Hamas terror cell operating near Israeli troops in northern Gaza
